Press Releases Stayble Therapeutics AB

Equities

STABL

SE0013513652

Delayed Nasdaq Stockholm Other stock markets 15:54:41 14/05/2024 BST			5-day change	1st Jan Change
0.2375 ^SEK	-0.63%		-13.79%	-21.62%

02-20	Stayble Therapeutics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
2023	Stayble Therapeutics Announces New Analyses of Phase IIb Study Strengthen Disc Herniation Project	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stayble's CEO to BioStock: "We are looking forward to new study results in 2024"	01-12	AQ
BioStock: Stayble's new analyses of phase IIb study strengthen disc herniation project	12-18	AQ
BioStock: Stayble Therapeutics shifts focus to phase Ib study in disc herniation	11-22	AQ
BioStock: Stayble did not reach the primary endpoint in phase IIb	11-09	AQ
BioStock: Stayble Therapeutics presents phase IIb data within one month	11-03	AQ
BioStock: Stayble reports last patient last visit in the phase IIb study	14/09/23	AQ
BioStock: Stayble enrols the first patient in herniated disc study	04/09/23	AQ
BioStock: Progress for Stayble Therapeutics in the second quarter	25/08/23	AQ
BioStock: Stayble's phase IIb study nears the finishing line	24/07/23	AQ
BioStock: Stayble Therapeutics looks towards its most important year so far	20/06/23	AQ
BioStock: Newly appointed CMO sees potential in Stayble Therapeutics	27/04/23	AQ
BioStock: Stayble presents additional positive interim data	18/04/23	AQ
BioStock: Stayble adds disc herniation to the pipeline - study approved	07/03/23	AQ
BioStock: Stayble is done with the 6-month follow-up	15/02/23	AQ
BioStock: Stayble approaches study results and other milestones	27/01/23	AQ
BioStock: Great interest at conferences for Stayble's treatment	15/12/22	AQ
Chronic Lower Back Pain Pipeline Offers Novel Treatment Options \| 10+ Companies & 10+ Drugs	06/12/22	AQ
BioStock at NLSDays: Stayble steps up partnering activities	04/10/22	AQ
BioStock: Stayble reaches important milestone - patient recruitment completed	05/09/22	AQ
BioStock: Stayble sums up and looks ahead	24/08/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Stayble Therapeutics AB

Equities

STABL

SE0013513652

Press Releases

Filters